-
Mashup Score: 200
Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.
Source: www.washingtonpost.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 3Addressing The Long COVID Quandary | Health Affairs Forefront - 2 month(s) ago
While the Trump administration is focused on cutting costs, addressing the gaps in care for millions of Americans with infection-associated chronic conditions—particularly Long COVID—cannot be overlooked.
Source: www.healthaffairs.orgCategories: General Medicine NewsTweet-
Hopefully @SecKennedy will consider the proposal @MVGutierrezMD and I outlined in @Health_Affairs Forefront: Addressing the #LongCOVID Quandary: https://t.co/QtvEaP7zGk https://t.co/U5F17OQld8
-
-
Mashup Score: 741Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID - 2 month(s) ago
Communications Medicine – Grady, Bhattacharjee and Silva et al. examine the effects of COVID-19 vaccination on 16 vaccine-naive individuals with Long COVID, finding that 10 reported improvements, 3…
Source: www.nature.comCategories: General Medicine NewsTweet-
This prospective observational study led by @connorbgrady @bornali_27 @SilvaJ_C @hmkyale examined the impact of the primary COVID-19 vaccination on the symptoms and immune signatures of 16 people with #longCOVID. Here is what we found 👇🏼 (1/) https://t.co/j3PV5qjnnZ
-
-
Mashup Score: 6【コロナ後遺症：『終わらないコロナ』前編】「丸太が何十本も…つぶされそう」後遺症と闘う19歳 コロナ５類移行２年の今、思うこと（テレビ信州） - Yahoo!ニュース - 2 month(s) ago
新型コロナが2類から5類に移行して、8日でちょうど2年になります。 普段の生活を取り戻し、新型コロナが過ぎ去ったかのような雰囲気も広がっていますが、その一方で、後遺症と闘っている人たちがいます。
Source: news.yahoo.co.jpCategories: General Medicine NewsTweet-
RT @NorioHonjo: 【コロナ５類移行２年】『終わらないコロナ』前編「丸太が何十本も…つぶされそう」後遺症と闘う19歳 コロナ５類移行２年の今、思うこと【長野】 #LongCovid https://t.co/AKi6YiDz0o
-
-
Mashup Score: 192Opinion | How to Lead a Chronic Disease Revolution - 2 month(s) ago
Washington has an opportunity to help tens of millions.
Source: www.wsj.comCategories: General Medicine News, Expert PicksTweet-
If we really want to take on chronic diseases..... by @virusesimmunity and @hmkyale #LongCovid, post-infection syndromes, immune system assessment and intervention gift link https://t.co/1IwOxZ529k https://t.co/PuAhaXwcN5
-
-
Mashup Score: 0From Lab to Life: What AI Tells Us About ‘Long Covid’ - 2 month(s) ago
In this episode of “From Lab to Life,” Keyla Sá, a researcher at Yale University School of Medicine, discusses her work tracking how long COVID develops and a new artificial intelligence tool that can identify the infection’s symptoms and patterns that scientists might not normally recognize.
Source: www.pewtrusts.orgCategories: General Medicine News, General NewsTweet-
What is #LongCOVID? Brain fog, fatigue, loss of smell/taste for 3+ months. Why does it happen? We don’t know yet. Keyla Sá of @YaleMed is investigating, and her research is changing lives. Listen to her story on “After the Fact.” 👇🎧 https://t.co/jtUq5zD6cn
-
-
Mashup Score: 0Nirmatrelvir-Ritonavir Shows Efficacy for Long COVID, But Lacks Significant Health Improvements - 3 month(s) ago
A new phase 2 trial raises questions about nirmatrelvir-ritonavir’s broader efficacy, as other studies highlight its effectiveness in reducing mortality among immunocompromised COVID-19 patients.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
A recent phase 2 trial published in @TheLancet evaluating nirmatrelvir-ritonavir for #LongCOVID showed no significant improvement in health outcomes, raising questions about its broader efficacy & emphasizing the need for tailored treatments. https://t.co/wtUkOy3GLN https://t.co/nmV05gSgU2
-
-
Mashup Score: 0From Lab to Life: What AI Tells Us About ‘Long Covid’ - 4 month(s) ago
In this episode of “From Lab to Life,” Keyla Sá, a researcher at Yale University School of Medicine, discusses her work tracking how long COVID develops and a new artificial intelligence tool that can identify the infection’s symptoms and patterns that scientists might not normally recognize.
Source: www.pewtrusts.orgCategories: General Medicine News, General NewsTweet-
What is #LongCOVID? Brain fog, fatigue, loss of smell/taste for 3+ months. Why does it happen? We don’t know yet. Keyla Sá of @YaleMed is investigating, and her research is changing lives. Listen to her story on “After the Fact.” 👇🎧 https://t.co/jtUq5zD6cn
-
-
Mashup Score: 0
This randomized clinical trial investigates whether donepezil may be effective against post–COVID-19 fatigue and psychological symptoms among patients within 1 year of COVID-19 diagnosis.
Source: jamanetwork.comCategories: General Medicine News, General HCPsTweet-
RCT: Donepezil hydrochloride did not improve fatigue or psychological symptoms in patients with post–COVID-19 condition. https://t.co/kX9DbFreMm #LongCOVID https://t.co/CbJGFBuQEM
-
-
Mashup Score: 3196Solving the puzzle of Long Covid - 4 month(s) ago
Long Covid provides an opportunity to understand how acute infections cause chronic disease
Source: www.science.orgCategories: General Medicine News, Expert PicksTweet-
Solving the puzzle of #LongCovid @ScienceMagazine today, @zalaly and I review what we know and what needs to be done https://t.co/nN50ke4Skx w/ @ScienceVisuals @ashleymastin_ + thanks @AldertonBiol for expert editing https://t.co/XId9k0mQnr
-
On finding treatments for #LongCovid “What’s so sad here is people are so desperate, and we don’t have anything [of so many solid candidates] validated." gift link: https://t.co/u8RoysHNJo